Inadequate use of asthma medication in the United States: Results of the Asthma in America national population survey
Inadequate use of asthma medication in the United States: Results of the Asthma in America national population survey
复制标题
DOI:
10.1067/mai.2002.125489
复制
发表时间:
2002-07-01
影响因子:
14.2
通讯作者:
Martinez, F
中科院分区:
文献类型:
--
作者:
Adams, RJ;Fuhlbrigge, A;Martinez, F
Background: Studies of the use of anti-inflammatory asthma therapy have been limited to selected populations or have been unable to assess the appropriateness of therapy for individuals.Objective: We sought to describe the current use of asthma medication in the United States population and to examine the influence of symptoms and sociodemographics on medication use.Methods: This study was based on a cross-sectional, national, random-digit-dial household telephone survey in 1998 designed to identify adult patients and parents of children with current asthma. Respondents were classified as having current asthma if they had a physician's diagnosis of asthma and were either taking medication for asthma or had asthma symptoms during the past year.Results: One or more persons met the study criteria for current asthma in 3273 (7.8%) households in which a screening questionnaire was completed. Of these, 2509 persons (721 children.,, 16 years) with current asthma were interviewed. Current use of anti-inflammatory medication was reported by 507 (20.1%). Of these, most were using inhaled corticosteroids (72.5%, with use of antileukotrienes reported by 11.4% and use of cromolyn-nedocromil reported by 18.6%. Of persons with persistent asthma symptoms in the past month, 26.2% reported current use of Some form of anti-inflammatory medication. In bivariate analysis persons reporting lower income, less education, and present unemployment, as well as smokers, were significantly (P